CUTR Cutera Inc: Long-Term Debt to Capital Coefficient

Corporate emblem and logo of Cutera, Inc. (CUTR)

This Cutera, Inc. (CUTR) price chart illustrates the asset's performance, with a value of 0.00. System assembly stability is maintained through diversified electronics and optics supply chains. Business revenues are based on the sale of truSculpt devices, Excel V lasers, and related consumables. Cutera, Inc. (CUTR) aims for dominance in the aesthetic niche by introducing updated devices that guarantee clinics rapid payback and safety.

CUTR - Cutera Inc. Long-Term Debt to Equity over the range 07/04/2022 - 03/22/2025
Brand item of Cutera Inc

When constructing a long-term portfolio, it is critical to assess the stability of the issuer's liability structure. This indicator correlates obligations with maturities exceeding one year against the amount of equity to determine the degree of financial leverage. For Cutera, Inc. (CUTR), this is critical, as falling demand for laser systems increases the burden of fixed costs. The current long-term debt-to-equity ratio visualizes the balance between leveraged scaling and the risk of insolvency.

Key competitors

Long-Term Loans to Capital Ratio DexCom Inc|Penumbra Corp (PEN) - Long-Term Debt to Capital|Long-Term Debt to Capital Coefficient Novanta Photonics (NOVT)|HAE: Long-Term Debt to Capital|inspiresleep.com - Long-Term Liabilities to Capital|Long-Term Debt to Equity PROCEPT BioRobotics Corporation (PRCT)|CNMD - Long-Term Debt to Capital Coefficient|PLSE: Long-Term Debt to Capital|INMD (InMode MD) - Long-Term Debt to Capital|Long-Term Debt to Equity Picard Medical Inc PMI|Long-Term Liabilities to Equity surmodics.com|Eversense - Long-Term Debt to Capital|Long-Term Liabilities to Capital NeuroPace Inc NPCE|Long-Term Debt to Equity Ratio TCMD (Tactile Medical)|SNWV - Long-Term Debt to Capital|Long-Term Debt to Equity Ratio Outset Medical, Inc. OM|ELMD - Long-Term Loans to Capital Ratio|LENSAR - Long-Term Debt to Capital|AVITA Medical Inc. (RCEL) - Ratio of Long-Term Indebtedness to Capital|Long-Term Debt to Capital PROF|Long-Term Debt to Equity Ratio Baird Medical Corp (BDMD)|EDAP TMS S.A. (EDAP) - Long-Term Debt to Equity Ratio|Long-Term Debt to Capital Coefficient APYX (apyxmedical.com)|IceCure Medical - Long-Term Debt to Equity|Long-Term Debt to Equity Ratio Pulmonx Corp LUNG|TELA (TELA Bio Corp) - Long-Term Debt to Capital|CTSO - Long-Term Liabilities to Capital|Long-Term Debt to Capital Sensus Healthcare, Inc.|zynex.com (ZYXI) - Long-Term Debt to Capital Ratio|ECOR: Long-Term Debt to Capital|Ratio of Long-Term Indebtedness to Capital Vicarious Surgical Corp|Long-Term Debt to Capital IINN (Inspira Technologies Oxy)|Long-Term Debt to Equity Ratio SeaStar Medical Holding Corp. (ICU)|Long-Term Debt to Capital IRIX (IRIDEX)|Intelligent Bio Solutions Inc - Long-Term Debt to Capital|XAIR - Long-Term Debt to Equity|Profusa Inc. (PFSA) - Long-Term Debt to Equity|Long-Term Debt to Equity Ratio strataskinsciences.com SSKN|GlucoTrack Inc. (GCTK) - Long-Term Debt to Capital Coefficient|Long-Term Debt to Capital NAOV (NanoVibronix, Inc.)|Long-Term Liabilities to Capital VERO|NUWE: Long-Term Debt to Equity|Long-Term Indebtedness to Equity Aethlon Medical Inc AEMD|Long-Term Debt to Equity Ratio ASXC (Asensus Surgical)|Long-Term Debt to Capital Avinger Inc AVGR|Long-Term Debt to Capital BSGM (BioSig)|KNW: Ratio of Long-Term Indebtedness to Capital|Long-Term Debt to Equity Inari Medical (NARI)|NVRO (Nevro Corp) - Long-Term Liabilities to Equity|Long-Term Debt to Equity RSLS|Long-Term Debt to Equity Ratio Silk Road Medical Inc